Melphalan Autologous Transplant
Conditions
Keywords
Nutrition Tool, Melphalan Autologous Transplant
Brief summary
The purpose of this pilot before and after interventional study is to determine if early intervention and provision of menus regarding appropriate diet choices for melphalan autologous transplant patients experiencing nausea and diarrhea will improve nutrition status and overall calorie and protein intake throughout the transplant process.
Interventions
OTHERSpecialized menu
-Specialized menu that will guide participant food choices if the participant experiences nausea or diarrhea
OTHERStandard of care menu
-Standard registered dietitian support
OTHERSelf report dietary intake worksheet
-Self report nausea and diarrhea
OTHERPost study questionnaire
-Completed upon count recovery and prior to discharge
Sponsors
Barnes-Jewish Hospital
Washington University School of Medicine
Study design
Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients undergoing melphalan autologous transplants will be included in this study * All patients that will be included in this pilot before and after interventional study will be inpatient on floors 5900, 6900 or 8900 of Barnes-Jewish Hospital * Per hospital protocol, all patients who will receive a melphalan autologous transplant will be admitted and remain inpatient for the duration of the transplant process. There will be no exclusion for dietary restrictions or food allergies as the foodservice provided to patients is room service, all food allergies are noted and suitable alternatives are provided as a standard of service. * Once a patient has been determined to meet criteria for the study, they will be approached by a member of the research team between day -2 and day 0 of transplant for consent. Patients must consent for the study by day +1 of transplant to be enrolled.
Exclusion criteria
* Patients \<18 years of age * Pregnant women * Prisoners * Patient unable to provide informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pre and post intervention mean total caloric intake | Through count recovery (10 days) |
| Mean total protein intake | Through count recovery (10 days) |
Secondary
| Measure | Time frame |
|---|---|
| Mean daily caloric intake | Through count recovery (10 days) |
| Mean daily protein intake | Through count recovery (10 days) |
Countries
United States
Outcome results
None listed